Prognosis
Biotechs Are Battling to Make the First Good Blood Test For Covid-19
Antibody tests are at the forefront of a push to assess who has potentially built up some immunity.
Photographer: Florian Plaucheur/AFP via Getty Images
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
When Gunther Burgard read about a new coronavirus spreading in China in early January, he convened his team at PharmAct AG to find out whether the biotech’s platform of finger-prick diagnostics could be put to work in the outbreak.